Sale!

Therapeutic Advances in Thrombosis 2nd Edition by David Moliterno, Steen Dalby Kristensen, Raffaele De Caterina 9781405196253 1405196254

Original price was: $50.00.Current price is: $35.00.

Therapeutic Advances in Thrombosis Second Edition David J. Moliterno Digital Instant Download

Author(s): David J. Moliterno, Steen Dalby Kristensen, Raffaele De Caterina
ISBN(s): 9781405196253, 1405196254
File Details: PDF, 3.34 MB
Year: 2012
Language: english
SKU: EB-4313196 Category: Tags: , ,

Therapeutic Advances in Thrombosis 2nd Edition by David Moliterno, Steen Dalby Kristensen, Raffaele De Caterina – Ebook PDF Instant Download/Delivery: 9781405196253, 1405196254

Full download Therapeutic Advances in Thrombosis 2nd Edition after payment

 

Product details:

ISBN 10: 1405196254

ISBN 13: 9781405196253

Author: David J. Moliterno, Steen Dalby Kristensen, Raffaele De Caterina

Managing patients with thrombotic vascular disease is complex and challenging:

  • Ischemic vascular disease remains a complicated interplay of atherosclerosis and thrombosis―even with the evolution in our understanding of the pathobiology of thrombosis.
  • There has been tremendous growth in therapeutic options which are quickly finding their place in daily practice, including a remarkable expansion in the number of intravenous and oral antithrombotic agents and new antiplatelet agents

Now more than ever, all cardiologists, hematologists, and specialists in vascular medicine, as well as other professionals, such as hospital pharmacists, who deal with prognosis and intervention in preventing thrombosis, need a resource that distills current knowledge of this important subject.

Written and edited by today’s leading international, Therapeutic Advances in Thrombosis, 2e provides physicians with the very latest in medical and surgical advances in antithrombotic therapies. With this comprehensively updated edition you get:

  • Coverage of virtually all aspects of venous and arterial thrombotic disease and the corresponding therapies
  • Strategies to manage specific clinical conditions and how to tailor treatment to individual patient needs
  • Updated chapters covering thrombolysis in ST-elevated myocardial infarctions; thrombosis in patients with diabetes, pregnancy, and renal dysfunction
  • Special emphasis on the pharmacology of novel anticoagulants and their practical use in venous thromboembolism and atrial fibrillation.

Plus, all chapters fully explore clinical trial designs and outcomes for particular treatment therapies, as well as contain the relevant ACC/AHA/ESC guidelines, so you can confidently apply what you learn.

Table of contents:

 

  1. Arterial thrombosis: a brief overview

  2. Aspirin

  3. Platelet ADP P2Y12 inhibitors: thienopyridines

  4. Platelet ADP P2Y12 inhibitors: nonthienopyridines

  5. Cilostazol and dipyridamole: more than weak inhibition of platelets

  6. Interrelationship of thrombin and platelets: the protease activated receptor-1

  7. Glycoprotein IIb/IIIa inhibitors

  8. Unfractionated heparin and low molecular weight heparin in ischemic heart disease

  9. Pentasaccharide derivatives

  10. Intravenous direct thrombin inhibitors

  11. Vitamin K antagonists

  12. Oral direct thrombin inhibitors and oral factor Xa inhibitors

  13. Thrombolytic therapy and concomitant antithrombotic therapies

  14. Antithrombotic therapy in ST-segment elevation myocardial infarction

  15. Antithrombotic therapy in non–ST-segment elevation acute coronary syndromes

  16. Antithrombotic strategies in patients undergoing elective percutaneous coronary intervention

  17. Antithrombotic management in patients with prosthetic valves

  18. Stroke: thrombolysis and antithrombotic therapy

  19. Atrial fibrillation: current and forthcoming antithrombotic therapies

  20. Venous thromboembolism: pathophysiology, diagnosis, and prophylaxis

  21. Antithrombotic therapy in venous thrombosis and pulmonary embolism

  22. Prevention and treatment of venous and arterial thrombosis in patients with specific conditions: diabetes, hypercoagulable states, pregnancy, and renal insufficiency

  23. Genetics of the response to antithrombotic drugs and the need for monitoring

People also search:

therapeutic anticoagulation dvt

therapeutic anticoagulation for covid

therapeutic anticoagulation in hospitalized patients with covid-19

therapeutic anticoagulation in covid patients

a therapeutic treatment involving administration

Tags: David Moliterno, Steen Dalby Kristensen, Raffaele De Caterina, Therapeutic